IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,547,000 | +8.0% | 520,000 | 0.0% | 0.77% | +15.2% |
| Q4 2021 | $6,063,000 | -10.7% | 520,000 | 0.0% | 0.67% | -14.5% |
| Q3 2021 | $6,791,000 | +1.5% | 520,000 | 0.0% | 0.78% | +6.8% |
| Q2 2021 | $6,692,000 | +15.1% | 520,000 | 0.0% | 0.74% | +5.5% |
| Q1 2021 | $5,814,000 | +1.7% | 520,000 | +3.6% | 0.70% | -20.9% |
| Q4 2020 | $5,716,000 | +26.6% | 501,874 | 0.0% | 0.88% | +7.6% |
| Q3 2020 | $4,514,000 | +6.8% | 501,874 | +22.6% | 0.82% | +6.1% |
| Q2 2020 | $4,226,000 | +946.0% | 409,500 | +923.8% | 0.77% | +841.5% |
| Q1 2020 | $404,000 | +344.0% | 40,000 | +378.6% | 0.08% | +583.3% |
| Q2 2019 | $91,000 | – | 8,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |